Freelance Niches with High Demand

Equity portfolio could lose a quarter in the event of extreme weather events and shed more than half from an AI correctionView the full article

Crown princess and a former prime minister are among those mentioned in new files released on FridayView the full article

Eurosceptic junior coalition partner quits after PM’s push to implement energy directives from BrusselsView the full article

Norges Bank Investment Management makes fresh bet on fortunes of UK capital’s retail and leisure districtView the full article

Norges Bank Investment Management to give $250mn mandates to external managersView the full article

World’s largest sovereign wealth fund is a top-10 investor at US electric vehicle makerView the full article

Donald The President’s vision to onshore factory jobs reverses decades of progressView the full article

From security services to those able to reinvent themselves, many may survive the AI armageddonView the full article

It turns out there is less to worry about than you might thinkView the full article

Deal would be biggest acquisition under chief executive Vas NarasimhanView the full article

Chair and six directors to leave as Danish drugmaker grapples with slowing growth and falling share priceView the full article

Danish maker of obesity drugs says that new leadership is neededView the full article

Danish group is struggling to compete with rival Eli Lilly View the full article

Lowest doses of Wegovy in oral form will start at $149 a month for US users until AprilView the full article

Shares in Danish drugmaker surge on positive signal from resultsView the full article

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatmentsView the full article

Participants with type 2 diabetes had an average weight loss of 15.7 per cent after 68 weeks on CagriSema View the full article

Outcome is blow to one of Europe’s largest listed companiesView the full article

Danish drugmaker reports rise in revenues but says prices under pressure as market becomes more crowdedView the full article

Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind View the full article

Results are due soon from two studies using semaglutide to treat thousands of people with the diseaseView the full article

The future of the post-1945 security order hangs in the balanceView the full article

It is possible to develop a model with the best intentions, and for that model to be misused later onView the full article

At a time when many question American leadership, there’s an underrated value in simply showing upView the full article

Deal for fledgling data centre provider is among the largest of its kind for a European tech start-upView the full article